N-pyridinyl(alkyl)polyhalogenobenzamides acting as TNF-α production inhibitors

Pharmacy and Pharmacology Communications

Volumn 5, Issue 3, 1999, Pages 233-238

  Collin, X ^a   Robert, J M ^a   Robert, S ^a   Le Baut, G ^a   Bobin Dubigeon, C ^a   Grimaud, N ^a   Lang, F ^a   Petit, J Y ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARRAGEENAN; IBUPROFEN; N (4,6 DIMETHYLPYRIDIN 2 YL)PENTAFLUOROBENZAMIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SYNTHESIS; INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0344075901     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128734659     Document Type: Conference Paper

References (25)

1. Alford, J. G., Stanley, P. L., Todderud, G., Tramposch, K. M. (1992) Infiltration of leukocyte subsets into mouse skin inflammation with phorbol ester. Agents Actions 37: 260-267
2. Arrieta, A., Cossio, F. P., Palomo, C. (1985) Synthesis of β-lactams from acetic acids and imines induced by phenyldichlorophosphate reagent. Tetrahedron 41: 1703-1712
3. Badger, A. M., Adams, J. L. (1998) New treatments for arthritis. Ann. Rep. Med. Chem. 33: 203-212
4. Beutler, B. (1992) Tumor necrosis factor: the molecules and their emerging role in medicine. Raven Press, New York
5. Carlson, R. P., O'Neil-Davis, L., Chang, J., Lewis, A. J. (1985) Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 17: 197-204
6. Collin, X., Robert, J. M., Robert-Piessard, S., Le Baut, G., Bobin-Dubigeon, C., Vernhet, L., Lang, F., Petit, J. Y. (1998) Synthesis and potent tumor necrosis factor-α production inhibitory activity of N-pyridinylphthalimides and derivatives. Pharm. Pharmacol. Commun. 4: 27-31
7. Duflos, M., Courant, J., Le Baut, G., Grimaud, N., Renard, P., Manechez, D., Caignard, D. H. (1998) 6-Amino-2,4-lutidine carboxamides: α-amino-amide derivatives as systemic and topical inflammation inhibitors. Eur. J. Med. Chem. 33: 635-645
8. Eigler, A., Sinha, B., Hartmann, G., Endres S. (1997) Taming TNF: strategies to restrain this proinflammatory cytokine. Immunology Today 10: 487-491
9. Elliot, M., Maini, R., Feldman, M., Long-Fox, A., Charles, P., Bijl, H., Woody, J. N. (1994) Repeated therapy with mAb to TNFα (cA2) in patients with rheumatoid arthritis. Lancet 344: 1125-1127
10. Espevik, T., Nissen-Meyer, J. (1986) A highly sensitive cell line, WEHI164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105
11. Fox, B. A., Threlfall, T. L. (1964) 2, 3-Diaminopyridine. Org. Synth. Coll. 44: 34-39
12. Graboyes, H., Day, A. R. (1957) Synthesis of some imidazopyridines and pyridotriazoles. J. Am. Chem. Soc. 79: 6421-6426
13. Lang, F., Robert, J. M., Boucrot, P., Welin, L., Petit, J. Y. (1995) New antiinflammatory compounds that inhibit tumor necrosis factor production: probable interaction with protein kinase C activation. J. Exp. Therap. 275: 171-176
14. Mariella, R. P., Belcher, E. P. J. (1952) The reactions of N-bromosuccinimide with some pyridine derivatives. J. Am. Chem. Soc. 74: 1916-1921
15. Muller, G. W., Corral, L. G., Shire, M. G., Wang, H., Moreira, A., Kaplan, G., Stirling, D. I. (1996) Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity. J. Med. Chem. 39: 3238-3240
16. Niwayama, S., Turk, B. E., Liu, J. O. (1996) Potent inhibition of tumor necrosis factor-α production by tetrafluorothalidomide and tetrafluorophtalimides. J. Med. Chem. 39: 3044-3045
17. Paul, R., Anderson, G. W. (1960) N, N′-carbonyldiimidazole, a new peptide forming reagent. J. Am. Chem. Soc. 92: 4596-4600
18. Robert, J. M. H., Robert-Piessard, S., Duflos, M., Le Baut, G., Khettab, E. N., Grimaud, N., Petit, J. Y., Welin, L. (1994) Non-acidic antiinflammatory compounds II. Synthesis and activity of 6-amino-2,4-lutidine derivatives. Eur. J. Med. Chem. 29: 841-854
19. Robert, J. M. H., Robert-Piessard, S., Courant, J., Le Baut, G., Robert, B., Lang, F., Petit, J. Y., Grimaud, N., Welin, L. (1995) Non-carboxylic antiinflammatory compounds. III. N-(4,6-dimethylpyridin-2-yl)arylcarboxamides and arylthiocarboxamides acting as brain edema inhibitors. Eur. J. Med. Chem. 30: 915-924
20. Sampaio, E., Sarno, E. N., Gallily, R., Cohn, Z. A., Kaplan, G. (1991) Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J. Exp. Med. 173: 699-703
21. Sander, O., Rau, R., Riel, P., van der Putte, L., Hasler, F., Baudin, M., Ludin, E., McAuliffe, T., Dickinson, S., Kahny, M., Lesslauer, W., Van der Auwera, P. (1996) Neutralisation of TNFα by lenercept (TNFsR55-IgG1, R0-45-2081) in patients with RA treated for 3 months. Arthritis Rheum. 39: S242
22. Tracey, K. J., Cerami, A. (1993) Tumor necrosis factor, other cytokines and diseases. Annu. Rev. Cell Biol. 9: 317-343
23. Trembly, B., Slikker, J. (1995) Neuroprotective agents: clinical and experimental aspects. Ann. NY Acad. Sci. 765: 62-71
24. Vernhet, L., Petit, J. Y., Lang, F. (1997) An anti-inflammatory benzamide derivative inhibits the protein kinase C (PKC)-dependent pathway of Erk2 phosphorylation in murine macrophages. J. Exptl. Therap. 283: 358-365
25. Winter, C. A., Risley, E. A., Nuss, G. W. (1962) Carrageenin-induced edema in hind paw of rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 11: 544-547